TradingView
RocketTickers
17 okt 2018 16:22

Eiger BioPharmaceuticals Announces Positive Results in Phase 2  Lång

NASDAQ:EIGR1D

Beskrivning

⋅
EIGR: Eiger BioPharmaceuticals, Inc.
2018-10-16 16:05:00
Eiger BioPharmaceuticals Announces Positive Results in Phase 2 PREVENT Study of Avexitide Targeting GLP-1 in Post-Bariatric Hypoglycemia (PBH)
Beyond Technical Analysis
Mer